JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Last updated: 01 November 2019
Pembrolizumab showed positive results in heavily pretreated, PD-L1–positive advanced esophageal carcinoma.Read more